Brown Advisory’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43K Hold
35,538
﹤0.01% 1384
2025
Q4
$44.4K Hold
35,538
﹤0.01% 1375
2025
Q3
$45.8K Hold
35,538
﹤0.01% 1371
2025
Q2
$69.3K Hold
35,538
﹤0.01% 1336
2025
Q1
$90.3K Buy
+35,538
New +$85.9K ﹤0.01% 1299
2024
Q2
Sell
-2,206
Closed -$13.5K 1233
2024
Q1
$13.5K Hold
2,206
﹤0.01% 1239
2023
Q4
$22K Hold
2,206
﹤0.01% 1210
2023
Q3
$14.2K Hold
2,206
﹤0.01% 1183
2023
Q2
$88.3K Hold
2,206
﹤0.01% 1152
2023
Q1
$64.5K Hold
2,206
﹤0.01% 1184
2022
Q4
$69.1K Hold
2,206
﹤0.01% 1179
2022
Q3
$64K Hold
2,206
﹤0.01% 1108
2022
Q2
$48K Hold
2,206
﹤0.01% 1085
2022
Q1
$68K Hold
2,206
﹤0.01% 1094
2021
Q4
$64K Hold
2,206
﹤0.01% 1220
2021
Q3
$104K Hold
2,206
﹤0.01% 1082
2021
Q2
$131K Hold
2,206
﹤0.01% 1043
2021
Q1
$144K Hold
2,206
﹤0.01% 1046
2020
Q4
$114K Hold
2,206
﹤0.01% 994
2020
Q3
$75K Hold
2,206
﹤0.01% 945
2020
Q2
$79K Hold
2,206
﹤0.01% 925
2020
Q1
$112K Hold
2,206
﹤0.01% 897
2019
Q4
$122K Hold
2,206
﹤0.01% 1007
2019
Q3
$113K Buy
+2,206
New +$158K ﹤0.01% 973

Other funds holding BCDA

Brown Advisory's BCDA Position: Q1 2026 in Review

Brown Advisory held its BioCardia (BCDA) position steady in Q1 2026 at 35,538 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Brown Advisory first reported a position in BCDA in Q3 2019 and has held it in 24 quarters since. The position peaked at $144K in Q1 2021. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Brown Advisory held 35,538 shares of BioCardia worth $43K as of Q1 2026.
  • Brown Advisory left its BioCardia share count unchanged in Q1 2026.
  • BioCardia made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1384 holding.
  • Brown Advisory first reported a position in BioCardia in Q3 2019 and has held it in 24 quarters since.
  • Brown Advisory's BioCardia position peaked at $144K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.